Top

Published in:

01-09-2012 | Original Communication

Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients

Authors: Roberto Erro, Gabriella Santangelo, Marina Picillo, Carmine Vitale, Marianna Amboni, Katia Longo, Angela Costagliola, Maria Teresa Pellecchia, Roberto Allocca, Anna De Rosa, Giuseppe De Michele, Lucio Santoro, Paolo Barone

Published in: Journal of Neurology | Issue 9/2012

Abstract

Little is known about the relationship between cognitive dysfunctions and the non-motor complex in subjects with newly diagnosed untreated Parkinson’s disease (PD). The aim of this study was to explore the association between non-motor symptoms (NMS) and cognitive dysfunctions in an incident cohort of de novo, drug-naive, PD patients. Sixty-six non-demented, early, untreated PD patients completed a semi-structured interview on NMS and a battery of neuropsychological tests that assess verbal memory, visuospatial abilities, and attention/executive functions. Scores were age- and education-corrected. Patients who failed at least two tests for each cognitive domain were diagnosed as having mild cognitive impairment (MCI). All but three (95.4%) PD patients complained of at least one NMS. A total of 37.8% was diagnosed with MCI. There was a relationship between sleep-NMS and cognitive dysfunctions. Specifically, both REM behavioral sleep disorders (RBD) and insomnia were associated with lower scores on several cognitive tests. Moreover, RBD was closely related to MCI. NMS and MCI are very common even in the early phase of PD, before patients are treated. Given the correlation between sleep disturbances and cognitive impairment, it is possible that sleep symptoms in PD patients might be considered as an early marker of dementia.

Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942PubMed

Findley L, Aujla M, Bain PG et al (2003) Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom. Mov Disord 18:1139–1145PubMedCrossRef

Shiba M, Bower JH, Maraganore DM et al (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 15:669–677PubMedCrossRef

Claassen DO, Josephs KA, Ahlskog JE et al (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75(6):494–499PubMedCrossRef

Park A, Stacy M (2009) Non-motor symptoms in Parkinson’s disease. J Neurol 256(Suppl 3):S293–S298CrossRef

Pacchetti C, Manni R, Zangaglia R et al (2005) Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 20:1439–1448PubMedCrossRef

Kehagia AA, Barker RA, Robbins WR (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213PubMedCrossRef

Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349PubMedCrossRef

Aarsland D, Andersen K, Larsen JP et al (2001) Risk of dementia in Parkinson’s disease. Neurology 56:730–736PubMedCrossRef

10.

Santangelo G, Vitale C, Trojano L et al (2009) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256(4):632–638PubMedCrossRef

11.

Pedersen KF, Alves G, Aarsland D et al (2009) Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80(11):1279–1282PubMedCrossRef

12.

Santangelo G, Trojano L, Vitale C et al (2007) A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations. Mov Disord 22(16):2418–2425PubMedCrossRef

13.

Marion MH, Qurashi M, Marshall G, Foster O (2008) Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson’s disease? J Neurol 255(2):192–196PubMedCrossRef

14.

Kulisevsky J, Garcia-Sanchez C, Berthier ML et al (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626PubMedCrossRef

15.

Fera F, Nicoletti G, Cerasa A et al (2007) Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson’s disease. Brain Res Bull 74:75–83PubMedCrossRef

16.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef

17.

Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676PubMedCrossRef

18.

Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9PubMedCrossRef

19.

Lang AE, Riley DE, Bergeron C (1994) Cortical-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. WB Saunders, Philadelphia, pp 877–894

20.

McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113–1124PubMedCrossRef

21.

Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedCrossRef

22.

Fahn S, Elton RL, UPDRS program members (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Mardsen CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Florham Park N, Macmillan Healthcare Information, pp 153–163

23.

Chaudhuri KR, Martinez-Martin P, Schapira AHV et al (2006) An international multicentre pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923PubMedCrossRef

24.

Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 6(Suppl 8):8–20

25.

American Psychiatric Association (1994) Diagnostic and statistical manual of mental health disorders, 4th edn. Washington, DC

26.

Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22(9):1272–1277PubMedCrossRef

27.

Chaudhuri KR, Naidu Y (2008) Early Parkinson’s disease and non-motor issues. J Neurol 255(suppl 5):33–38PubMedCrossRef

28.

Dhawan V, Dhoat S, Williams AJ et al (2006) The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurol Sci 248:158–162PubMedCrossRef

29.

Müller B, Larsen JP, Wentzel-Larsen T et al (2011) Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 26(1):65–72PubMedCrossRef

30.

Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649PubMedCrossRef

31.

Iranzo A, Molinuevo JL, Santamaría J et al (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572–577PubMedCrossRef

32.

Aarsland D, Brønnick K, Larsen JP et al (2009) Cognitive impairment in incident untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72(13):1121–1126PubMedCrossRef

33.

Foltynie T, Brayne CE, Robbins TW et al (2004) The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain 127(Pt 3):550–560PubMed

34.

Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245PubMedCrossRef

35.

Aarsland D, Cummings JL, Larsen JP (2001) Neuropsychiatric differences between Parkinson’s disease with dementia and Alzheimer’s disease. Int J Geriatr Psychiatry 16:184–191PubMedCrossRef

36.

Bronnick K, Aarsland D, Larsen JP (2005) Neuropsychiatric disturbances in Parkinson’s disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand 112:201–207PubMedCrossRef

37.

Naismith SL, Lewis SJG (2011) “DASH” symptoms in patients with Parkinson’s disease: red flags for early cognitive decline. J Clin Neurosci 18(3):352–355PubMedCrossRef

38.

Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474PubMedCrossRef

39.

Perez-Lloret S, Rossi M, Cardinali DP, Merello M (2008) Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest). Parkinsonism Relat Disord 14(8):641–645PubMedCrossRef

40.

Gagnon JF, Vendette M, Postuma RB et al (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47PubMedCrossRef

41.

Vendette M, Gagnon JF, Décary A et al (2007) REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 69(19):1843–1849PubMedCrossRef

42.

Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2:229–237PubMedCrossRef

43.

Braak H, Rüb U, Jansen Steur EN et al (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404–1410PubMedCrossRef

44.

Emre M (2004) Dementia in Parkinson’s disease: cause and treatment. Curr Opin Neurol 17(4):399–404PubMedCrossRef

Title: Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients
Authors: Roberto Erro
Gabriella Santangelo
Marina Picillo
Carmine Vitale
Marianna Amboni
Katia Longo
Angela Costagliola
Maria Teresa Pellecchia
Roberto Allocca
Anna De Rosa
Giuseppe De Michele
Lucio Santoro
Paolo Barone
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 9/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6407-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2012

Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation

Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab

Myopathy caused by anoctamin 5 mutations and necrotizing vasculitis

Migraine with aura in patients over 50 years of age: the Marseille’s registry

Health-related quality of life in Huntington’s disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington’s disease health-related quality of life questionnaire (HDQoL)

Subacute progressive ophthalmoplegia associated with dermatomyositis